Objective
To report discordant phenotypes, resulting from the same mutation in exon ORF15 (GenBank AF286472) of the retinitis pigmentosa GTPase regulator gene (RPGR) (GenBank U57629), in 2 presumed dizygotic twin brothers with X-linked retinal disease.
Methods
The 2 brothers underwent complete ophthalmic examination that included best-corrected visual acuity, slitlamp biomicroscopy, and detailed fundus examination. Visual field recording using Goldmann kinetic perimetry and a full-field electroretinogram were also obtained in both patients. Mutational screening was performed for RPGR because of an X-linked pattern of inheritance indicated by pedigree analysis.
Results
One brother had a phenotypic expression of cone-rod dystrophy, while the other exhibited X-linked retinitis pigmentosa. A 1-nucleotide deletion was identified in the 3′ region of exon ORF15 of RPGR (ORF15 + 1339delA).
Conclusions
An identical mutation in RPGR-ORF15 manifested distinct clinical phenotypes in individuals of the same family. Our data provide strong evidence in support of additional modifier genes that can produce diverse disease phenotypes in patients with RPGR mutations.
Clinical Relevance
The clinical observation of different retinal phenotypes in a family with the same mutation in exon ORF15 of RPGR implicates the potential importance of modifier genes for the phenotypic expression of this form of X-linked retinal disease.
Mutations in the retinitis pigmentosa (RP) GTPase regulator gene (RPGR) account for 80% to 90% of X-linked RP and almost 25% of male subjects with simplex RP.1-4 Most RPGR mutations are detected in exon ORF15, which encodes a repetitive glycine and glutamic acid–rich domain of unknown function.5 The RPGR-ORF15 isoforms are preferentially expressed in cells with primary cilia.6-8 The high mutability of exon ORF15 seems to be related to unusual nucleotide composition or to the repetitive nature of its sequence. This type of sequence may adopt unusual conformations, including triplex structures, which are associated with reduced fidelity of replication.9 Exon ORF15 contains numerous potential polymerase arrest sites, suggesting that arrest may occur during replication, leading to slipped-strand mispairing events, as many mutations involve direct repeats.10
Patients with mutations in the 3′ region of exon ORF15 have primarily demonstrated cone-rod dystrophies and milder forms of RP,2,11,12 while mutations closer to the 5′ region are detected in more severe forms of X-linked RP.1,5,13-15 Mutations in this exon have also been shown to cause cone dystrophy5,16 and atrophic macular degeneration.17 However, discordant phenotypes within the same family have not been reported, to our knowledge. Herein, we describe a family with 2 male presumed dizygotic twins in whom an identical mutation in exon ORF15 resulted in 2 different phenotypes.
Patients and clinical analysis
Informed consent was obtained from the patients. The research protocol was approved by institutional review boards at the University of Illinois, Chicago, and the University of Michigan, Ann Arbor.
A 52-year-old man (patient III-1) reported a history of decreased vision in his left eye at the age of 49 years (Figure 1). Previous records showed that at 14 years of age his visual acuity was 20/20 OD and 20/30 OS. The fundus appearance at that time suggested early central choroidal atrophy. Progressive worsening of vision in both eyes continued thereafter. The patient reported being extremely sensitive to bright light but had no subjective loss of night or peripheral vision. Difficulty with color perception had also been noted by the patient. He had undergone a laser in situ keratomileusis (LASIK) procedure in both eyes 4 years previously. His medical history was significant for hypertension, which was well controlled with medication. His family history revealed a pedigree consistent with an X-linked pattern of inheritance.
On ophthalmic examination, best-corrected visual acuity on a Snellen visual acuity chart was 20/400 OD and 20/200 OS. He could read 20/50 OU for near vision with an × 7 magnifier. On testing for color vision using Ishihara pseudoisochromatic plates, he was able to identify only a single plate with either eye. Anterior segment examination using slitlamp biomicroscopy showed the presence of corneal scars temporally in both eyes from the LASIK procedure flaps. The intraocular pressure was 15 mm Hg OU. A fundus examination showed grossly normal optic discs and retinal vessel attenuation in both eyes. A bilateral bull's eye–appearing macular lesion was present in each eye with a tapetal type sheen temporal to the macula (Figure 2).
Visual field examination using Goldmann kinetic perimetry showed only mild peripheral restriction with the V-4-e, III-4-e, and II-4-e test targets and the presence of a central scotoma to the III-4-e and II-4-e targets in the right eye and to the II-4-e target in the left eye (Figure 3 and Figure 4). An electroretinogram (ERG) was obtained using a unipolar Burian-Allen contact lens electrode, as described previously.18 Stimuli were presented in a commercial recording unit (Nicolet Ganzfeld; Nicolet Biomedical Inc, Madison, Wisconsin), and signals were acquired (Nicolet Viking IV system, Nicolet Biomedical Inc). The patient's dark-adapted b-wave responses to short wavelength and to maximal flash stimuli were 296 μV (within the lower normal range of 273-684 μV) and 359 μV (22% below the lower range of normal, 461-908 μV), respectively . The light-adapted brief flash b-wave amplitude was 34 μV (82% below the lower range of normal, 133-320 μV), and the amplitude for the light-adapted 32-Hz flicker was 25 μV (81% below the lower range of normal, 131-354 μV) (Figure 5). The clinical phenotype and ERG recordings were consistent with cone-rod dystrophy in this patient.
The presumed dizygotic twin brother of patient III-1 (patient III-2 in Figure 1) was seen at the University of Illinois at the age of 52 years. He gave a history of impaired peripheral vision and nyctalopia since the age of 10 years. Retinitis pigmentosa was diagnosed when the patient was 12 years old. His visual acuity at age 14 years was 20/30 OD and 20/50 OS; the fundus had a tessellated myopic appearance. At that time, a non-Ganzfeld ERG was nondetectable under light-adapted and dark-adapted conditions. Progressive worsening of impaired peripheral vision and nyctalopia, more in the left eye, was noted by the patient, and he reported having very poor vision in the left eye for the past 20 years. There was less severe subjective impairment of central acuity in the right eye. His other symptoms included photosensitivity and difficulty with color vision. His medical history was significant for asthma, hypertension, and gastric reflux disease.
The patient's most recent best-corrected visual acuity was 20/50−1 OD measured by Snellen visual acuity chart and light perception in the left eye with temporal projection. He could read J1 on a Jaeger near vision chart using an × 7 magnifier with his right eye. He had 30° to 40° of left exotropia. Anterior segment examination showed the presence of pseudophakia in the right eye and moderate posterior capsular, nuclear, and anterior cortical cataract in the left eye. Fundus examination showed the presence of bilateral optic disc pallor and retinal vessel attenuation. There was an atrophic appearance of the retinal pigment epithelium within the posterior pole in both eyes, with relative sparing of the foveal region in the right eye. Moderately extensive midperipheral bone spicule pigment clumping was also seen in both eyes (Figure 6). Visual using a Goldmann perimeter showed severe peripheral field loss in each eye to even a V-4-e test target (Figure 7). An ERG recording showed nondetectable cone or rod responses. This patient's phenotype was consistent with an X-linked form of RP.
Blood samples were obtained from the twins for the purpose of genetic analysis. Lymphocyte DNA was used for amplification of exon ORF15 of RPGR using 1 forward and 4 reverse primers as described by Demirci et al.11
High-fidelity DNA Taq polymerase (AccuPrime; Invitrogen, San Diego, California) was used to amplify a fragment of approximately 1.9 kilobase (kb). Polymerase chain reaction (PCR) reagents were 5 μL of the enzyme PCR buffer, 200nM of each forward and reverse primer, and 1 μL of DNA at 50 to 100 ng/μL. The reaction volume was made to 50 μL with PCR water. Reaction tubes were placed in a PCR machine (model 9700; Applied Biosystems, Norwalk, Connecticut) and were run on the following program: 94°C for 2 minutes, followed by 10 cycles at 92°C for 30 seconds, and then 56°C annealing and 68°C for 2 minutes. This was followed by 25 cycles at 92°C for30 seconds, annealing at 60°C for 30 seconds, and extension at 68°C for 2.5 minutes. Further extension was done at 68°C for 20 minutes and then held at 4°C. The PCR-amplified products were run on 1% agarose gels with a 1-kb ladder to check the product size and quality before sending the PCR products for sequencing. Sequencing was performed by the Biomedical Research Core Facility at the University of Michigan. RPGR-ORF15 PCR products were sequenced using the relative primers as in the referenced article.11 Chromatograms were read using a demonstration version of the sequencer software to help in identifying the sequence variants compared with normal sequences.
The mutation identified in each subject was ORF15 + 1339delA. This mutation is predicted to result in a frameshift and premature truncation of the protein. It was previously identified by Bader et al15 and by Sandberg et al19 in patients with X-linked RP.
Previous studies1-6,11-16,19 identified that ORF15 mutations can cause cone-rod dystrophy or an RP phenotype. Our findings show that even among individuals of the same family the same genetic mutation may present distinct phenotypes. In a study by Demirci et al,11 a 2-nucleotide deletion involving the same location, ORF15 + 1339_1340delAG, was shown to be associated with X-linked cone-rod dystrophy. A more severe form of X-linked RP was believed to be associated with mutations at the 5′ region of RPGR-ORF15.2 However, 1 of our patients demonstrates that a mutation at the 3′ end of exon ORF15 may also express a severe form of X-linked RP, as measured by visual field and ERG testing. A similar observation was reported by Sandberg et al.19
It would be valuable to identify the factors responsible for the different phenotypes that can occur with the same genotype. Our findings in the 2 presumed dizygotic twins carrying the same RPGR-ORF15 mutation suggest that modifier genes are likely to significantly contribute to an individual's phenotype. It is possible that environmental factors may also modulate a disease phenotype to some degree. Nevertheless, additional genetic analysis would seem prudent in families that show intrafamilial variation in the phenotype of their retinal disease yet carry similar causative mutations.
Correspondence: Gerald A. Fishman, MD, Department of Ophthalmology and Visual Sciences, University of Illinois, Mail Code 648, Room 3.85, 1855 W Taylor St, Chicago, IL 60612-7234.
Submitted for Publication: June 8, 2007;final revision received July 26, 2007; accepted July 30, 2007.
Financial Disclosure: None reported.
Funding/Support: This study was supported by funds from the Foundation Fighting Blindness, Grant Healthcare Foundation (Dr Fishman), and Research to Prevent Blindness (Dr Fishman).
Additional Contributions: Sharyn Ferrara, BA, provided administrative assistance.
1.Breuer
DKYashar
BMFilippova
E
et al. A comprehensive mutation analysis of
RP2 and
RPGR in a North American cohort of families with X-linked retinitis pigmentosa.
Am J Hum Genet 2002;70
(6)
1545- 1554
PubMedGoogle ScholarCrossref 2.Sharon
DSandberg
MARabe
VWStillberger
MDryja
TPBerson
EL
RP2 and
RPGR mutations and clinical correlations in patients with X-linked retinitis pigmentosa.
Am J Hum Genet 2003;73
(5)
1131- 1146
PubMedGoogle ScholarCrossref 3.Pelletier
VJambou
MDelphin
N
et al. Comprehensive survey of mutations in
RP2 and
RPGR in patients affected with distinct retinal dystrophies: genotype-phenotype correlations and impact on genetic counseling.
Hum Mutat 2007;28
(1)
81- 91
PubMedGoogle ScholarCrossref 5.Vervoort
RLennon
ABird
AC
et al. Mutational hot spot within a new
RPGR exon in X-linked retinitis pigmentosa.
Nat Genet 2000;25
(4)
462- 466
PubMedGoogle ScholarCrossref 6.Hong
DHYue
GAdamian
MLi
T Retinitis pigmentosa GTPase regulator (RPGRr)–interacting protein is stably associated with the photoreceptor ciliary axoneme and anchors RPGR to the connecting cilium.
J Biol Chem 2001;276
(15)
12091- 12099
PubMedGoogle ScholarCrossref 8.Khanna
HHurd
TWLillo
C
et al.
RPGR-ORF15, which is mutated in retinitis pigmentosa, associates with SMC1, SMC3, and microtubule transport proteins.
J Biol Chem 2005;280
(39)
33580- 33587
PubMedGoogle ScholarCrossref 9.Wang
GSeidman
MMGlazer
PM Mutagenesis in mammalian cells induced by triple helix formation and transcription-coupled repair.
Science 1996;271
(5250)
802- 805
PubMedGoogle ScholarCrossref 10.Roepman
RBauer
DRosenberg
T
et al. Identification of a gene disrupted by a microdeletion in a patient with X-linked retinitis pigmentosa (XLRP).
Hum Mol Genet 1996;5
(6)
827- 833
PubMedGoogle ScholarCrossref 11.Demirci
FYRigatti
BWWen
G
et al. X-linked cone-rod dystrophy (locus
COD1): identification of mutations in
RPGR exon ORF15.
Am J Hum Genet 2002;70
(4)
1049- 1053
PubMedGoogle ScholarCrossref 12.Ebenezer
NDMichaelides
MJenkins
SA
et al. Identification of novel
RPGR ORF15 mutations in X-linked progressive cone-rod dystrophy (XLCORD) families.
Invest Ophthalmol Vis Sci 2005;46
(6)
1891- 1898
PubMedGoogle ScholarCrossref 13.Mears
AJHiriyanna
SVervoort
R
et al. Remapping of the
RP15 locus for X-linked cone-rod degeneration to Xp11.4-p21.1, and identification of a de novo insertion in the
RPGR exon ORF15.
Am J Hum Genet 2000;67
(4)
1000- 1003
PubMedGoogle ScholarCrossref 14.Yokoyama
AMaruiwa
FHayakawa
M
et al. Three novel mutations of the
RPGR gene exon ORF15 in three Japanese families with X-linked retinitis pigmentosa.
Am J Med Genet 2001;104
(3)
232- 238
PubMedGoogle ScholarCrossref 15.Bader
IBrandau
OAchatz
H
et al. X-linked retinitis pigmentosa:
RPGR mutations in most families with definite X linkage and clustering of mutations in a short sequence stretch of exon ORF15.
Invest Ophthalmol Vis Sci 2003;44
(4)
1458- 1463
PubMedGoogle ScholarCrossref 16.Yang
ZPeachey
NSMoshfeghi
DM
et al. Mutations in the
RPGR gene cause X-linked cone dystrophy.
Hum Mol Genet 2002;11
(5)
605- 611
PubMedGoogle ScholarCrossref 17.Ayyagari
RDemirci
FYLiu
J
et al. X-linked recessive atrophic macular degeneration from
RPGR mutation.
Genomics 2002;80
(2)
166- 171
PubMedGoogle ScholarCrossref 18.Peachey
NSFishman
GADerlacki
DJAlexander
KR Rod and cone dysfunction in carriers of X-linked retinitis pigmentosa.
Ophthalmology 1988;95
(5)
677- 685
PubMedGoogle ScholarCrossref 19.Sandberg
MARosner
BWeigel-DiFranco
CDryja
TPBerson
EL Disease course of patients with X-linked retinitis pigmentosa due to
RPGR gene mutations.
Invest Ophthalmol Vis Sci 2007;48
(3)
1298- 1304
PubMedGoogle ScholarCrossref